Vildagliptin 50 mg & 15mg Pioglitazone Hydrochloride

Jun 19, 2023

Vildagliptin 50 mg & Pioglitazone Hydrochloride 15 mg
VILDIABATE PIO  
Vildagliptin is an oral antidiabetic medication that belongs to the class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones help regulate blood sugar levels by increasing insulin secretion and reducing the production of glucagon, a hormone that raises blood sugar levels. Vildagliptin is typically used in combination with other antidiabetic medications, such as metformin, to help improve glycemic control in patients with type 2 diabetes.
Pioglitazone hydrochloride, often referred to as pioglitazone, is an oral antidiabetic medication classified as a thiazolidinedione (TZD) or glitazone. It works by improving insulin sensitivity in muscle and fat tissues, which helps the body effectively utilize insulin and control blood sugar levels. Pioglitazone primarily acts as an insulin sensitizer and does not directly increase insulin secretion. It is commonly used as an adjunct to diet and exercise to manage type 2 diabetes when other medications, such as metformin or sulfonylureas, are not sufficient on their own.
STERIS PHARMA Generic medicines are typically much cheaper than brand-name drugs. Generic medicines have the same active ingredients, strength, dosage form, and route of administration as their brand-name counterparts.
For further information please contact:
contact@sterispharma.com
order now: https://www.sterisonline.com/product/vildiabate-pio-134257

SHARE WITH